| Clinical outcomes and prognostic factors in patients with breast diffuse large B cell lymphoma; Consortium for Improving Survival of Lymphoma (CISL) study HY Yhim, HJ Kang, YH Choi, SJ Kim, WS Kim, YS Chae, JS Kim, CW Choi, ... BMC cancer 10, 1-12, 2010 | 102 | 2010 |
| Imatinib mesylate discontinuation in patients with chronic myeloid leukemia who have received front-line imatinib mesylate therapy and achieved complete molecular response HY Yhim, NR Lee, EK Song, CY Yim, SY Jeon, S Shin, JA Kim, HS Kim, ... Leukemia research 36 (6), 689-693, 2012 | 82 | 2012 |
| Prevention of venous thromboembolism: korean society of thrombosis and hemostasis evidence-based clinical practice guidelines SM Bang, MJ Jang, KH Kim, HY Yhim, YK Kim, SH Nam, HG Hwang, ... Journal of Korean medical science 29 (2), 164-171, 2014 | 77 | 2014 |
| Clinical outcomes and prognostic factors of up-front autologous stem cell transplantation in patients with extranodal natural killer/T cell lymphoma HY Yhim, JS Kim, YC Mun, JH Moon, YS Chae, Y Park, JC Jo, SJ Kim, ... Biology of Blood and Marrow Transplantation 21 (9), 1597-1604, 2015 | 74 | 2015 |
| Matched‐pair analysis comparing the outcomes of primary breast and nodal diffuse large B‐cell lymphoma in patients treated with rituximab plus chemotherapy HY Yhim, JS Kim, HJ Kang, SJ Kim, WS Kim, CW Choi, HS Eom, JA Kim, ... International journal of cancer 131 (1), 235-243, 2012 | 73 | 2012 |
| Incidence of venous thromboembolism in Korea from 2009 to 2013 J Hong, JH Lee, HY Yhim, WI Choi, SM Bang, H Lee, D Oh PloS one 13 (1), e0191897, 2018 | 72 | 2018 |
| Incidence of venous thromboembolism following major surgery in Korea: from the Health Insurance Review and Assessment Service database HY Yhim, MJ Jang, SM Bang, KH Kim, YK Kim, SH Nam, SH Bae, SH Kim, ... Journal of thrombosis and haemostasis 12 (7), 1035-1043, 2014 | 69 | 2014 |
| The prognostic significance of tumor human papillomavirus status for patients with anal squamous cell carcinoma treated with combined chemoradiotherapy HY Yhim, NR Lee, EK Song, JY Kwak, ST Lee, JH Kim, JS Kim, HS Park, ... International journal of cancer 129 (7), 1752-1760, 2011 | 68 | 2011 |
| Prognostic factors for recurrent breast cancer patients with an isolated, limited number of lung metastases and implications for pulmonary metastasectomy HY Yhim, SW Han, DY Oh, W Han, SA Im, TY Kim, YT Kim, DY Noh, ... Cancer 116 (12), 2890-2901, 2010 | 67 | 2010 |
| Minimal residual disease-based effect and long-term outcome of first-line dasatinib combined with chemotherapy for adult Philadelphia chromosome-positive acute lymphoblastic … JH Yoon, HY Yhim, JY Kwak, JS Ahn, DH Yang, JJ Lee, SJ Kim, JS Kim, ... Annals of Oncology 27 (6), 1081-1088, 2016 | 60 | 2016 |
| Clinical features of severe acquired ADAMTS13 deficiency in thrombotic thrombocytopenic purpura: the Korean TTP registry experience MJ Jang, SY Chong, IH Kim, JH Kim, CW Jung, JY Kim, JC Park, SM Lee, ... International journal of hematology 93, 163-169, 2011 | 50 | 2011 |
| Clinical outcome of elderly patients with Epstein–Barr virus positive diffuse large B‐cell lymphoma treated with a combination of rituximab and CHOP chemotherapy JS Ahn, DH Yang, Y Duk Choi, SH Jung, HY Yhim, JY Kwak, H Sung Park, ... American journal of hematology 88 (9), 774-779, 2013 | 42 | 2013 |
| Phase II trial of concurrent chemoradiotherapy with L-asparaginase and MIDLE chemotherapy for newly diagnosed stage I/II extranodal NK/T-cell lymphoma, nasal type (CISL-1008) DH Yoon, SJ Kim, SH Jeong, DY Shin, SH Bae, J Hong, SK Park, ... Oncotarget 7 (51), 85584, 2016 | 39 | 2016 |
| Pharmacological thromboprophylaxis and its impact on venous thromboembolism following total knee and hip arthroplasty in Korea: a nationwide population-based study HY Yhim, J Lee, JY Lee, JO Lee, SM Bang PloS one 12 (5), e0178214, 2017 | 38 | 2017 |
| Management of immune thrombocytopenia: Korean experts recommendation in 2017 JH Jang, JY Kim, YC Mun, SM Bang, YJ Lim, DY Shin, YB Choi, HY Yhim, ... Blood research 52 (4), 254, 2017 | 35 | 2017 |
| Matched-pair analysis to compare the outcomes of a second salvage auto-SCT to systemic chemotherapy alone in patients with multiple myeloma who relapsed after front-line auto-SCT HY Yhim, K Kim, JS Kim, HJ Kang, JA Kim, CK Min, SH Bae, E Park, ... Bone marrow transplantation 48 (3), 425-432, 2013 | 34 | 2013 |
| Seasonal variation in the occurrence of venous thromboembolism: a report from the Korean Venous Thromboembolism Working Party MJ Jang, HJ Kim, SM Bang, JO Lee, HY Yhim, YK Kim, YK Kim, W Choi, ... Thrombosis research 130 (4), e199-e202, 2012 | 34 | 2012 |
| Clinical outcome and prognosis of patients with primary sinonasal tract diffuse large B-cell lymphoma treated with rituximab-cyclophosphamide, doxorubicin, vincristine and … GW Lee, SI Go, SH Kim, J Hong, YR Kim, S Oh, SY Kim, YR Do, H Lee, ... Leukemia & lymphoma 56 (4), 1020-1026, 2015 | 33 | 2015 |
| Use of curcumin to decrease nitric oxide production during the induction of antitumor responses by IL-2 MY Song, JY Yim, JM Yim, IJ Kang, HW Rho, HS Kim, HY Yhim, NR Lee, ... Journal of Immunotherapy 34 (2), 149-164, 2011 | 32 | 2011 |
| Successful treatment of myelodysplastic syndrome and Behcet colitis after allogeneic hematopoietic stem cell transplantation MH Kook, HY Yhim, NR Lee, EK Song, HS Kim, CY Yim, JY Kwak The Korean Journal of Internal Medicine 29 (1), 123, 2014 | 25 | 2014 |
Won Seog kimSamsung Medical Center在 skku.edu 的電子郵件地址已通過驗證
